NCT06542887View on ClinicalTrials.gov

Black Seed Oil in ADHD

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
ADHD
Interventions
DRUG

Atomoxetine

Participants will continue receiving their treatment with atomoxetine at a dose of 0.5-1.4 mg/kg/day

DRUG

Black Seed Oil Cap/Tab

Participants will receive black seed oil in the form of soft gelatin capsule 450 mg at a dose of 40-80 mg/kg/day given in one to two divided doses after meals for 12 weeks.

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06542887 - Black Seed Oil in ADHD | Biotech Hunter | Biotech Hunter